Scholar Rock Holding Corporation
NASDAQ:SRRKBiotechnology
+$0.49 today
- Market cap
- $5.86B
- Beta
- 0.69
- P/E (TTM)
- -14.8
- EPS (TTM)
- -$3.21
Volume 2.77M
Average 1.46M
SRRK Interest Expense
Cost of servicing the company's debt during the period.
Scholar Rock Holding CorporationNASDAQ: SRRK
Interest Expense · Q3 FY2026 · quarter ended Sep 2026
Interest expense grows, but more slowly than its trailing trend
Q3 FY2026 interest expense of $4.63M rose 247.4% year over year, behind the +450.7% change in trailing-twelve-month interest expense. Sequentially, it rose 2.6% from the prior quarter.
Context
- Interest expense increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +247.4% toward the trailing-twelve-month pace of +450.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 6.89M USD
- Year-over-year change
- +0.8%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.89M | +0.8% |
| FY2024 | 2024-12-31 | 6.84M | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Interest Expense vs competitors
How SRRK compares with its peers on the latest reported figures
- SRRK's LTM Sep 2026 interest expense of $13.99M is the 6th highest of the 11 companies compared; the peer median is $9.15M.
- Its year-over-year change of +450.7% is the 3rd highest of 7, against a peer median of +75.3%.
- Interest expense amounts to 2454.0% of revenue for SRRK, versus a peer median of 7.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $185.29M | +25.9% | +18.8% | 18.4% | |
| LTM Jun 2026 | $89.83M | -32.3% | -12.9% | 12.6% | |
| LTM Sep 2026 | $76.07M | -16.1% | +123.4% | 7.9% | |
| LTM Mar 2026 | $42.07M | +124.6% | -43.3% | 1.9% | |
| LTM Jun 2026 | $14.9M | +15745.7% | +28.5% | — | |
| LTM Sep 2026 | $13.99M | +450.7% | — | 2454.0% | |
| LTM Mar 2026 | $3.41M | +340500.0% | — | 10.6% | |
| LTM Mar 2026 | $866K | — | — | 4.3% | |
| LTM Sep 2026 | $0 | — | — | — | |
| LTM Sep 2026 | $0 | — | — | — | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SRRK) | $9.15M | +75.3% | +18.8% | 7.9% | |
Competitors are the stored peer set for SRRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 18.82M | 33.19M | 0 | 0 | 0 |
| Cost of Revenue | 108.47M | 123.04M | 2.84M | 1.94M | 208.44M |
| Gross Profit | (89.65M) | (89.85M) | (2.84M) | (1.94M) | (208.44M) |
| Gross Margin | -476.5% | -270.7% | — | — | — |
| Research & Development | 108.47M | 124.44M | 119.06M | 182.61M | 208.44M |
| Selling, General & Admin | 40.27M | 42.62M | 49.4M | 67.5M | 176.21M |
| Operating Expenses | 40.27M | 44.52M | 168.45M | 250.12M | 176.21M |
| Depreciation & Amortization | 2.63M | 2.99M | 2.84M | 1.94M | 1.66M |
| EBITDA | (129.17M) | (129.48M) | (162.95M) | (237.52M) | (369.39M) |
| EBITDA Margin | -686.5% | -390.1% | — | — | — |
| Operating Income | (129.92M) | (134.37M) | (171.3M) | (252.05M) | (384.65M) |
| Operating Margin | -690.5% | -404.8% | — | — | — |
| Interest Income | 0 | 0 | 0 | 12.68M | 13.9M |
| Interest Expense | 0 | 0 | 0 | 6.84M | 6.89M |
| Other Income / Expenses | (1.88M) | (132K) | 5.51M | 5.76M | 6.71M |
| Income Before Tax | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Pre-Tax Margin | -700.5% | -405.2% | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Net Margin | -700.5% | -405.2% | — | — | — |
| EPS (Basic) | (3.59) | (2.21) | (1.99) | (2.47) | (3.29) |
| EPS (Diluted) | (3.59) | (2.21) | (1.99) | (2.47) | (3.29) |
| Weighted Avg Shares | 36.71M | 59.61M | 75.98M | 99.84M | 114.7M |
| Weighted Avg Shares (Diluted) | 36.71M | 59.61M | 75.98M | 99.84M | 114.7M |
Scholar Rock Holding Corporation
NASDAQ:SRRK
Intrinsic Alpha fair value
Locked
Current Price
$48.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.